Ledger.Open graph →
SEC Form D · filed August 15, 2017

Orbus Therapeutics, Inc

Offering
$24.5M
Sold
$12.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Gary R. Price · Cincinnati, OHDirectorRichard Silas · VANCOUVER, British Columbia, CanadaExec · DirectorJoseph Gabor · Thornton, PADirectorSusan E. Fasig · Cincinnati, OHExec · DirectorJulie T. Thomas · Cincinnati, OHDirectorRick Trotman · VANCOUVER, British Columbia, CanadaDirectorSharding Management Management LLC · Dover, DEDirectorKingsley Advani · Dover, DEDirectorVilleneuve Robin · Quebec, Quebec, CanadaExec · DirectorJeffrey A. Coopersmith · Columbus, OHDirectorJames L. Hall · Salt Lake City, UTDirectorFrancois Goulet · Montreal, Quebec, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗